Genetic variations at the LPL and apoAI-apoCIII loci influence lipid and lipoprotein levels, but these effects are strongly modulated by smoking status and gender.
No takes yet. Share an insight, caveat, or question.
May inform smoking-specific lipid risk assessment; leaves open whether LPL variants alter clinical management pending longitudinal validation.
Peacock et al. (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: